NASDAQ
Annovis Bio, Inc. (ANVS) has a current ratio of 5.80x as of Monday, May 25, 2026. This represents a 43.68% decrease compared to its 12-month average of 10.30x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.